The ASX200 has recently climbed 0.67% to reach a record high of 8,504 points, buoyed by positive sentiment and a strong lead from Wall Street as the market enjoys the Santa rally. While traditional sectors like Discretionary and Financials are seeing gains, investors may also consider exploring opportunities in smaller or newer companies often referred to as penny stocks. Despite the term’s outdated connotation, these stocks can offer significant growth potential when backed by solid financials and sound fundamentals.
|
Name |
Share Price |
Market Cap |
Financial Health Rating |
|
Embark Early Education (ASX:EVO) |
A$0.79 |
A$144.95M |
★★★★☆☆ |
|
LaserBond (ASX:LBL) |
A$0.565 |
A$66.23M |
★★★★★★ |
|
Helloworld Travel (ASX:HLO) |
A$2.03 |
A$330.52M |
★★★★★★ |
|
Austin Engineering (ASX:ANG) |
A$0.54 |
A$334.88M |
★★★★★☆ |
|
MaxiPARTS (ASX:MXI) |
A$1.76 |
A$97.36M |
★★★★★★ |
|
EZZ Life Science Holdings (ASX:EZZ) |
A$2.41 |
A$111.24M |
★★★★★★ |
|
SHAPE Australia (ASX:SHA) |
A$2.75 |
A$228.01M |
★★★★★★ |
|
Navigator Global Investments (ASX:NGI) |
A$1.65 |
A$808.63M |
★★★★★☆ |
|
Vita Life Sciences (ASX:VLS) |
A$2.03 |
A$114.16M |
★★★★★★ |
|
Servcorp (ASX:SRV) |
A$4.87 |
A$480.5M |
★★★★☆☆ |
Click here to see the full list of 1,044 stocks from our ASX Penny Stocks screener.
Let’s review some notable picks from our screened stocks.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: IVE Group Limited operates in the marketing sector in Australia, with a market capitalization of A$336.11 million.
Operations: The company’s revenue from the advertising segment is A$972.82 million.
Market Cap: A$336.11M
IVE Group Limited, with a market capitalization of A$336.11 million, shows promising financial health despite its high debt levels. The company’s earnings have grown significantly by 61% over the past year, outpacing the media industry average. Short-term assets cover both short and long-term liabilities, indicating strong liquidity. However, the net debt to equity ratio is high at 64.2%, which may be a concern for investors wary of leverage risks. While trading below its estimated fair value suggests potential upside, investors should weigh this against the sustainability of its dividend and overall financial stability before considering an investment in IVE Group Limited.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Microba Life Sciences Limited offers microbiome testing, supplements, and analysis services across various regions including Australia, Europe, and the United States, with a market cap of A$76.13 million.
